INVITAE CORP's ticker is NVTA and the CUSIP is 46185L103. A total of 194 filers reported holding INVITAE CORP in Q4 2019. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,000,184 | -44.3% | 1,652,650 | +4.0% | 0.00% | -50.0% |
Q2 2023 | $1,794,917 | -5.6% | 1,588,422 | +12.7% | 0.00% | 0.0% |
Q1 2023 | $1,901,895 | -27.8% | 1,408,811 | -0.5% | 0.00% | -42.9% |
Q4 2022 | $2,633,169 | -40.8% | 1,415,682 | -21.7% | 0.01% | -41.7% |
Q3 2022 | $4,446,000 | +5.7% | 1,807,429 | +4.8% | 0.01% | +9.1% |
Q2 2022 | $4,207,000 | -67.2% | 1,724,117 | +7.3% | 0.01% | -21.4% |
Q1 2022 | $12,808,000 | -14.9% | 1,606,924 | +63.0% | 0.01% | -56.2% |
Q4 2021 | $15,056,000 | -51.6% | 985,993 | -10.0% | 0.03% | -59.5% |
Q3 2021 | $31,137,000 | -21.4% | 1,095,201 | -6.7% | 0.08% | -28.8% |
Q2 2021 | $39,601,000 | +22.0% | 1,174,068 | +38.2% | 0.11% | -1.8% |
Q1 2021 | $32,467,000 | +38.1% | 849,688 | +51.1% | 0.11% | +29.9% |
Q4 2020 | $23,511,000 | +18.2% | 562,337 | +22.5% | 0.09% | -12.1% |
Q3 2020 | $19,892,000 | +787.6% | 458,867 | +520.1% | 0.10% | +607.1% |
Q2 2020 | $2,241,000 | +342.9% | 73,995 | +99.8% | 0.01% | +250.0% |
Q1 2020 | $506,000 | -4.7% | 37,036 | +12.5% | 0.00% | +33.3% |
Q4 2019 | $531,000 | +6.8% | 32,915 | +27.6% | 0.00% | 0.0% |
Q3 2019 | $497,000 | – | 25,799 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EMORY UNIVERSITY | 104,861 | $1,560,000 | 2.11% |
Baker Brothers Advisors | 6,554,967 | $97,538,000 | 0.86% |
SECTORAL ASSET MANAGEMENT INC | 929,765 | $13,835,000 | 0.58% |
Camber Capital Management LP | 500,000 | $7,440,000 | 0.51% |
Rock Springs Capital Management LP | 400,000 | $5,952,000 | 0.43% |
Redmile Group, LLC | 181,224 | $2,563,000 | 0.21% |
Perceptive Advisors | 299,583 | $2,306,000 | 0.14% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 166,666 | $2,480,000 | 0.08% |
CORRADO ADVISORS, LLC | 11,860 | $176,000 | 0.08% |
Orbimed Advisors | 456,666 | $6,795,000 | 0.05% |